title: Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients?
authors.forename: P
authors.initials: P
authors.lastname: Zola
authors.forename: A
authors.initials: A
authors.lastname: Ferrero
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage; D015996:Survival Rate
chemical_list: D016190:Carboplatin; D017239:Paclitaxel